Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,421 to 1,440 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decade-long leukaemia remissions with persistence of CD4+ CAR T cells. | Nature | 2022 | 35110735 | PubTator, text mining | PubMed |
| How Single-Cell Technologies Have Provided New Insights Into Atherosclerosis. | Arterioscler Thromb Vasc Biol | 2022 | 35109673 | PubTator, text mining | PubMed |
| Dissecting the heterogeneity of the microenvironment in primary and recurrent nasopharyngeal carcinomas using single-cell RNA sequencing. | Oncoimmunology | 2022 | 35096485 | PubTator, text mining | PubMed |
| Characterizing cellular heterogeneity in fibrotic hypersensitivity pneumonitis by single-cell transcriptional analysis. | Cell Death Discov | 2022 | 35091537 | PubTator, text mining | PubMed |
| Comparative study of SARS-CoV-2 infection in different cell types: Biophysical-computational approach to the role of potential receptors. | Comput Biol Med | 2022 | 35077937 | PubTator, text mining | PubMed |
| An atlas of dynamic peripheral blood mononuclear cell landscapes in human perioperative anaesthesia/surgery. | Clin Transl Med | 2022 | 35061932 | PubTator, text mining | PubMed |
| Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion. | J Exp Med | 2022 | 35061012 | PubTator, text mining | PubMed |
| Challenges and Opportunities for the Translation of Single-Cell RNA Sequencing Technologies to Dermatology. | Life (Basel) | 2022 | 35054460 | PubTator, text mining | PubMed |
| Biomarkers in EndoVascular Aneurysm Repair (EVAR) and Abdominal Aortic Aneurysm: Pathophysiology and Clinical Implications. | Diagnostics (Basel) | 2022 | 35054350 | PubTator, text mining | PubMed |
| Potential Role of CXCL13/CXCR5 Signaling in Immune Checkpoint Inhibitor Treatment in Cancer. | Cancers (Basel) | 2022 | 35053457 | PubTator, text mining | PubMed |
| Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women. | Lancet Healthy Longev | 2022 | 35047868 | PubTator, text mining | PubMed |
| SARS-CoV-2 (COVID-19) Adhesion Site Protein Upregulation in Small Airways, Type 2 Pneumocytes, and Alveolar Macrophages of Smokers and COPD - Possible Implications for Interstitial Fibrosis. | Int J Chron Obstruct Pulmon Dis | 2022 | 35046647 | PubTator, text mining | PubMed |
| Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy. | Nitric Oxide | 2022 | 35032641 | PubTator, text mining | PubMed |
| Complement activation induces excessive T cell cytotoxicity in severe COVID-19. | Cell | 2022 | 35032429 | PubTator, text mining | PubMed |
| Circulating CD8+ mucosal-associated invariant T cells correlate with improved treatment responses and overall survival in anti-PD-1-treated melanoma patients. | Clin Transl Immunology | 2022 | 35028137 | PubTator, text mining | PubMed |
| Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. | Nat Rev Cardiol | 2022 | 35027697 | PubTator, text mining | PubMed |
| Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma. | Sci Rep | 2022 | 35027623 | PubTator, text mining | PubMed |
| Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. | PLoS Pathog | 2022 | 35025971 | PubTator, text mining | PubMed |
| Sequencing of Systemic Therapies in the Management of Advanced Prostate Cancer in India: a Delphi-Based Consensus. | Oncol Ther | 2022 | 35025089 | PubTator, text mining | PubMed |
| Functional phenotyping of circulating human cytotoxic T cells and NK cells using a 16-color flow cytometry panel. | STAR Protoc | 2022 | 35024627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=72